118 related articles for article (PubMed ID: 33667891)
1. The value of circulating tumor cells with positive centromere probe 8 in the diagnosis of small pulmonary nodules.
Liu C; Chen H; Sun T; Wang H; Chen B; Wang X
Transl Oncol; 2021 May; 14(5):101052. PubMed ID: 33667891
[TBL] [Abstract][Full Text] [Related]
2. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
3. Detection of circulating rare cells benefitted the diagnosis of malignant solitary pulmonary nodules.
Xie J; Ruan Z; Zheng J; Gong Y; Wang Y; Hu B; Cheng J; Huang Q
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2681-2692. PubMed ID: 34791530
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
[TBL] [Abstract][Full Text] [Related]
5. Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules.
Ma G; Yang D; Li Y; Li M; Li J; Fu J; Peng Z
Thorac Cancer; 2022 Dec; 13(23):3393-3401. PubMed ID: 36284506
[TBL] [Abstract][Full Text] [Related]
6. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
[TBL] [Abstract][Full Text] [Related]
7. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
[TBL] [Abstract][Full Text] [Related]
9. Value of circulating tumor cells in the diagnosis and treatment of solitary pulmonary nodules.
Liu D; Mao Y; Ma H
Ann Transl Med; 2021 Mar; 9(6):501. PubMed ID: 33850898
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of circulating tumor cells detection in renal cell carcinoma with thrombus: A STROBE-compliant study.
Ge L; Song Y; Yang F; Zhao G; Lu M; Zhang S; Ma L
Medicine (Baltimore); 2020 May; 99(22):e20615. PubMed ID: 32481476
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
14. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
[TBL] [Abstract][Full Text] [Related]
15. Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer.
Lei Y; Sun N; Zhang G; Liu C; Lu Z; Huang J; Zhang C; Zang R; Che Y; Mao S; Fang L; Wang X; Zheng S; He J
Clin Transl Med; 2020 Jul; 10(3):e128. PubMed ID: 32659050
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
Sun B; Liu H; Wang S; Xiang J; Liu X
J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
Shishido SN; Carlsson A; Nieva J; Bethel K; Hicks JB; Bazhenova L; Kuhn P
J Transl Med; 2019 Aug; 17(1):294. PubMed ID: 31462312
[TBL] [Abstract][Full Text] [Related]
18. Dynamic enhancement patterns of solitary pulmonary nodules at multi-detector row CT and correlation with vascular endothelial growth factor and microvessel density.
Jiang NC; Han P; Zhou CK; Zheng JL; Shi HS; Xiao J
Ai Zheng; 2009 Feb; 28(2):164-9. PubMed ID: 19550130
[TBL] [Abstract][Full Text] [Related]
19. [Detection and clinical significance of circulating tumor cells in osteosarcoma using immunofluorescence combined with in situ hybridization].
Zhang HQ; Li MH; Wang Z; Lan PH; Lu YJ; Chen GJ; Wang L
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):485-489. PubMed ID: 28728292
[No Abstract] [Full Text] [Related]
20. Circulating Tumor Cells as a Biomarker to Assist Molecular Diagnosis for Early Stage Non-Small Cell Lung Cancer.
He Y; Shi J; Schmidt B; Liu Q; Shi G; Xu X; Liu C; Gao Z; Guo T; Shan B
Cancer Manag Res; 2020; 12():841-854. PubMed ID: 32104066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
